SAB BIOTHERAPEUTICS, INC. (SABSW) Operating cash flow 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$44.8MFY2025 · since FY2020: $10.0M → -$44.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$44.8M | -30.6% |
| FY2024 | -$34.3M | -36.5% |
| FY2023 | -$25.1M | -7.1% |
| FY2022 | -$23.5M | -1280.7% |
| FY2021 | $2.0M | -80.1% |
| FY2020 | $10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SABSW financial trends
SABSW RevenueSABSW Net incomeSABSW Net marginSABSW Gross profitSABSW Gross marginSABSW Operating incomeSABSW Operating marginSABSW Free cash flowSABSW Capital expendituresSABSW Return on equitySABSW Stock buybacksSABSW Dividends paidSABSW Total assetsSABSW Total liabilitiesSABSW Shareholders’ equitySABSW overview →